
The active suppression of immune responses against tumor is a major barrier to the likely success of cancer zzso There is now compelling evidence implicating T regulatory cells zzso as being key players driving immune zzso zzso zzso of zzso within the peripheral circulation and tumor zzso of cancer patients correlate with poor prognosis and reduced zzso zzso the mechanism of zzso zzso is critical for the development of new approaches aiming to zzso the frequency and function of zzso to enhance the efficacy of cancer zzso zzso 

This review focuses on current knowledge concerning zzso in cancer and discusses putative mechanisms which zzso the expansion of zzso in cancer zzso Additionally, we review current strategies to zzso zzso activity, the limitations of these strategies and future perspective for improving their zzso 

An insight of the current aspects concerning zzso zzso in cancer and an overview of recent advances in the identification of zzso zzso in addition to the potential strategies to target zzso for enhancing zzso zzso 

zzso by which zzso functions zzso the immune response to tumors are becoming further zzso However, specific markers to zzso zzso are yet to be clearly identified, which is a major limitation in zzso strategies to specifically target zzso in zzso Despite this, strategies aimed at modulating zzso in patients are providing some early encouraging results supporting the overall concept and indicating that further studies are clearly zzso 

